Compare OGN & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | PAYO |
|---|---|---|
| Founded | 1923 | 2005 |
| Country | United States | United States |
| Employees | N/A | 2540 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2020 | N/A |
| Metric | OGN | PAYO |
|---|---|---|
| Price | $13.43 | $7.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $11.40 | $7.69 |
| AVG Volume (30 Days) | 2.6M | ★ 13.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | $7.15 |
| Revenue Next Year | $1.67 | $10.28 |
| P/E Ratio | ★ $24.42 | $30.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $4.08 |
| 52 Week High | $13.49 | $7.67 |
| Indicator | OGN | PAYO |
|---|---|---|
| Relative Strength Index (RSI) | 72.03 | 80.66 |
| Support Level | $10.05 | $5.50 |
| Resistance Level | $13.46 | N/A |
| Average True Range (ATR) | 0.05 | 0.30 |
| MACD | -0.11 | 0.16 |
| Stochastic Oscillator | 57.14 | 98.60 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.